185 related articles for article (PubMed ID: 34439794)
1. Anthraquinones as Inhibitors of SOS RAS-GEF Activity.
Fernández-Medarde A; Fuentes-Mateos R; García-Navas R; Juan AO; Sánchez-López JM; Fernández-Medarde A; Santos E
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439794
[TBL] [Abstract][Full Text] [Related]
2. Small molecule binding sites on the Ras:SOS complex can be exploited for inhibition of Ras activation.
Winter JJ; Anderson M; Blades K; Brassington C; Breeze AL; Chresta C; Embrey K; Fairley G; Faulder P; Finlay MR; Kettle JG; Nowak T; Overman R; Patel SJ; Perkins P; Spadola L; Tart J; Tucker JA; Wrigley G
J Med Chem; 2015 Mar; 58(5):2265-74. PubMed ID: 25695162
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic RAS isoforms show a hierarchical requirement for the guanine nucleotide exchange factor SOS2 to mediate cell transformation.
Sheffels E; Sealover NE; Wang C; Kim DH; Vazirani IA; Lee E; M Terrell E; Morrison DK; Luo J; Kortum RL
Sci Signal; 2018 Sep; 11(546):. PubMed ID: 30181243
[TBL] [Abstract][Full Text] [Related]
4. Rational design of small molecule inhibitors targeting the Ras GEF, SOS1.
Evelyn CR; Duan X; Biesiada J; Seibel WL; Meller J; Zheng Y
Chem Biol; 2014 Dec; 21(12):1618-28. PubMed ID: 25455859
[TBL] [Abstract][Full Text] [Related]
5. High-throughput screening identifies small molecules that bind to the RAS:SOS:RAS complex and perturb RAS signaling.
Burns MC; Howes JE; Sun Q; Little AJ; Camper DV; Abbott JR; Phan J; Lee T; Waterson AG; Rossanese OW; Fesik SW
Anal Biochem; 2018 May; 548():44-52. PubMed ID: 29444450
[TBL] [Abstract][Full Text] [Related]
6. SOS GEFs in health and disease.
Baltanás FC; Zarich N; Rojas-Cabañeros JM; Santos E
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188445. PubMed ID: 33035641
[TBL] [Abstract][Full Text] [Related]
7. Small Molecule-Mediated Activation of RAS Elicits Biphasic Modulation of Phospho-ERK Levels that Are Regulated through Negative Feedback on SOS1.
Howes JE; Akan DT; Burns MC; Rossanese OW; Waterson AG; Fesik SW
Mol Cancer Ther; 2018 May; 17(5):1051-1060. PubMed ID: 29440291
[TBL] [Abstract][Full Text] [Related]
8. Recent progress in developing small molecule inhibitors designed to interfere with ras membrane association: toward inhibiting K-Ras and N-Ras functions.
Tamanoi F; Lu J
Enzymes; 2013; 34 Pt. B():181-200. PubMed ID: 25034105
[TBL] [Abstract][Full Text] [Related]
9. Combined rational design and a high throughput screening platform for identifying chemical inhibitors of a Ras-activating enzyme.
Evelyn CR; Biesiada J; Duan X; Tang H; Shang X; Papoian R; Seibel WL; Nelson S; Meller J; Zheng Y
J Biol Chem; 2015 May; 290(20):12879-98. PubMed ID: 25825487
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Son of sevenless by the membrane-actin linker protein ezrin.
Geissler KJ; Jung MJ; Riecken LB; Sperka T; Cui Y; Schacke S; Merkel U; Markwart R; Rubio I; Than ME; Breithaupt C; Peuker S; Seifert R; Kaupp UB; Herrlich P; Morrison H
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20587-92. PubMed ID: 24297905
[TBL] [Abstract][Full Text] [Related]
11. Approach for targeting Ras with small molecules that activate SOS-mediated nucleotide exchange.
Burns MC; Sun Q; Daniels RN; Camper D; Kennedy JP; Phan J; Olejniczak ET; Lee T; Waterson AG; Rossanese OW; Fesik SW
Proc Natl Acad Sci U S A; 2014 Mar; 111(9):3401-6. PubMed ID: 24550516
[TBL] [Abstract][Full Text] [Related]
12. RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1.
Chen SH; Gong X; Zhang Y; Van Horn RD; Yin T; Huber L; Burke TF; Manro J; Iversen PW; Wu W; Bhagwat SV; Beckmann RP; Tiu RV; Buchanan SG; Peng SB
Oncogene; 2018 Feb; 37(6):821-832. PubMed ID: 29059158
[TBL] [Abstract][Full Text] [Related]
13. Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS-SOS1 interaction.
Hillig RC; Sautier B; Schroeder J; Moosmayer D; Hilpmann A; Stegmann CM; Werbeck ND; Briem H; Boemer U; Weiske J; Badock V; Mastouri J; Petersen K; Siemeister G; Kahmann JD; Wegener D; Böhnke N; Eis K; Graham K; Wortmann L; von Nussbaum F; Bader B
Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2551-2560. PubMed ID: 30683722
[TBL] [Abstract][Full Text] [Related]
14. Unusual interplay of two types of Ras activators, RasGRP and SOS, establishes sensitive and robust Ras activation in lymphocytes.
Roose JP; Mollenauer M; Ho M; Kurosaki T; Weiss A
Mol Cell Biol; 2007 Apr; 27(7):2732-45. PubMed ID: 17283063
[TBL] [Abstract][Full Text] [Related]
15. Antibody targeting intracellular oncogenic Ras mutants exerts anti-tumour effects after systemic administration.
Shin SM; Choi DK; Jung K; Bae J; Kim JS; Park SW; Song KH; Kim YS
Nat Commun; 2017 May; 8():15090. PubMed ID: 28489072
[TBL] [Abstract][Full Text] [Related]
16. An effector region in Eps8 is responsible for the activation of the Rac-specific GEF activity of Sos-1 and for the proper localization of the Rac-based actin-polymerizing machine.
Scita G; Tenca P; Areces LB; Tocchetti A; Frittoli E; Giardina G; Ponzanelli I; Sini P; Innocenti M; Di Fiore PP
J Cell Biol; 2001 Sep; 154(5):1031-44. PubMed ID: 11524436
[TBL] [Abstract][Full Text] [Related]
17. Coupling of Ras and Rac guanosine triphosphatases through the Ras exchanger Sos.
Nimnual AS; Yatsula BA; Bar-Sagi D
Science; 1998 Jan; 279(5350):560-3. PubMed ID: 9438849
[TBL] [Abstract][Full Text] [Related]
18. Molecular assemblies of the catalytic domain of SOS with KRas and oncogenic mutants.
Moghadamchargari Z; Shirzadeh M; Liu C; Schrecke S; Packianathan C; Russell DH; Zhao M; Laganowsky A
Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33723061
[TBL] [Abstract][Full Text] [Related]
19. Membrane-dependent signal integration by the Ras activator Son of sevenless.
Gureasko J; Galush WJ; Boykevisch S; Sondermann H; Bar-Sagi D; Groves JT; Kuriyan J
Nat Struct Mol Biol; 2008 May; 15(5):452-61. PubMed ID: 18454158
[TBL] [Abstract][Full Text] [Related]
20. Structural fingerprints, interactions, and signaling networks of RAS family proteins beyond RAS isoforms.
Nakhaei-Rad S; Haghighi F; Nouri P; Rezaei Adariani S; Lissy J; Kazemein Jasemi NS; Dvorsky R; Ahmadian MR
Crit Rev Biochem Mol Biol; 2018 Apr; 53(2):130-156. PubMed ID: 29457927
[No Abstract] [Full Text] [Related]
[Next] [New Search]
